Provectus Biopharmaceuticals Inc. Appoints Christopher Kaplan To Its Strategic Advisory Board

free biotech news Get the latest biotech news where you 

want it. Sign up for the free GenePool newsletter today!

Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT) (http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company (“Provectus”), announced today that it has appointed Christopher Kaplan to its Strategic Advisory Board effective immediately.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC